Phenylurea derivatives used as inhibitors of tyrosinkinase for treating tumors

Details for Australian Patent Application No. 2005297531 (hide)

Owner Merck Patent GmbH

Inventors Rautenberg, Wilfried; Staehle, Wolfgang; Hoelzemann, Guenter

Agent Davies Collison Cave

Pub. Number AU-B-2005297531

PCT Pub. Number WO2006/042599

Priority 04024368.5 13.10.04 DE

Filing date 16 September 2005

Wipo publication date 27 April 2006

Acceptance publication date 23 June 2011

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 June 2007 PCT application entered the National Phase

  PCT publication WO2006/042599 Priority application(s): WO2006/042599

23 June 2011 Application Accepted

  Published as AU-B-2005297531

20 October 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005297538-Method and device for continuously producing a thin metal strip

2005297530-Method for producing olefin oxides and peroxides, reactor and the use thereof